H
Hajra Zafar
Researcher at Shanghai Jiao Tong University
Publications - 6
Citations - 167
Hajra Zafar is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Nanomedicine & Nanocarriers. The author has an hindex of 4, co-authored 6 publications receiving 48 citations. Previous affiliations of Hajra Zafar include Quaid-i-Azam University.
Papers
More filters
Journal ArticleDOI
Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
TL;DR: In this article, the use of biomimetic nanotechnology for developing effective cancer immunotherapeutics that demonstrate increased specificity and potency has been discussed, and the recent works and state-of-the-art strategies for anti-tumor immunotherapy are highlighted.
Journal ArticleDOI
Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers.
TL;DR: A diverse range of nanotargeted drug-delivery systems based on self-assembled peptide carrier systems have been developed in recent years for cancer targeting and are discussed.
Journal ArticleDOI
Recent progress on nanomedicine-induced ferroptosis for cancer therapy.
TL;DR: In this article, the feasibility and properties of nanomedicine-based ferroptosis in cancer therapy is highlighted. And the current research on the applications of nanomedical applications for the ferroptic-based anticancer therapy are highlighted.
Journal ArticleDOI
Design of enzyme decorated mucopermeating nanocarriers for eradication of H. pylori infection
Hajra Zafar,Hajra Zafar,Maria Hassan Kiani,Faisal Raza,Aisha Rauf,Iqra Chaudhery,Nasir M. Ahmad,Sohail Akhtar,Gul Shahnaz +8 more
TL;DR: Amoxicillin loaded papain modified thiolated polycarbophil nanocarrier system was able to completely eradicate H. pylori infection that was attributed to its enhanced mucopermeating and mucoadhesive nature and showed an interesting future potential for infectious therapy.
Journal ArticleDOI
Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs.
TL;DR: In this paper, the authors reviewed the recent advancements in gelatin-based nanomedicine for use in cancer therapeutics and evaluated the drawbacks and challenges of gelatin nanoparticles for cancer therapy.